Interestingly, it has been demonstrated that miR‐135a exerts a protective role via promotion of proliferation and suppression of apoptosis and neuroinflammation by targeting GSK3β in MPP+‐intoxicated SH‐SY5Y cells, providing a potential therapeutic target for the treatment of Parkinson disease.17 This evidence concerns the gene GSK3B and Parkinson disease.